First-half 2026 revenue grew 7.4% at constant rates, driven by strong performances in both companion and farm animal segments, with notable contributions from Supercharge platforms and the Thyronorm acquisition. Guidance for 2026 is confirmed at the upper end, with robust margins and cash generation expected.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.